Back
Plus Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
PSTV
Plus Therapeutics
Last Price:
$0.38
Seasonality Move:
-14.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.34 | Buy |
20-day SMA: | 0.3 | Buy |
50-day SMA: | 0.36 | Buy |
200-day SMA: | 0.94 | Sell |
8-day EMA: | 0.3 | Buy |
20-day EMA: | 0.19 | Buy |
50-day EMA: | 0.09 | Buy |
200-day EMA: | 0.03 | Buy |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 56.04 | Buy |
Chaikin Money Flow: | 9546315 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.26 - 0.36) | Buy |
Bollinger Bands (100): | (0.27 - 0.97) | Sell |
Plus Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.38 while PSTV 8-day simple moving average is 0.34, which is a Buy signal.
-
The stock price of PSTV is 0.38 while Plus Therapeutics 20-day SMA is 0.30, which makes it a Buy.
-
Plus Therapeutics 50-day simple moving average is 0.36 while PSTV share price is 0.38, making it a Buy technically.
-
PSTV stock price is 0.38 and Plus Therapeutics 200-day simple moving average is 0.94, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
30
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a SellThe current Plus Therapeutics [PSTV] share price is $0.38. The Score for PSTV is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
12.5M
Price in USD:
0.38
Share Volume:
9.5M
Plus Therapeutics 52-Week Range
52-Week High:
2.31
52-Week Low:
0.16
Sell
30
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?The Plus Therapeutics stock price is 0.38 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 0.38 while PSTV 8-day exponential moving average is 0.30, which is a Buy signal.
-
The stock price of PSTV is 0.38 while Plus Therapeutics 20-day EMA is 0.19, which makes it a Buy.
-
Plus Therapeutics 50-day exponential moving average is 0.09 while PSTV share price is 0.38, making it a Buy technically.
-
PSTV stock price is 0.38 and Plus Therapeutics 200-day simple moving average is 0.03, creating a Buy signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.46 per share, and a decrease next year of $0.28 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Plus Therapeutics is a Buy
-
Plus Therapeutics Relative Strength Index (RSI) is 56.04, which suggest Plus Therapeutics is overbought
-
The Bollinger Bands (25) for Plus Therapeutics is (0.26 - 0.36), which suggest Plus Therapeutics is a Sell
-
The Bollinger Bands (100) for Plus Therapeutics is (0.27 - 0.97), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.